http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20110557-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_480374e8b8cf1df220e0116adbf62fe7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2011-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f08a74e20ae10fa6997073525783aacc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db9102a5f101d5b25003c34e569ea4e9
publicationDate 2011-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HR-P20110557-T1
titleOfInvention NEW COMPOUNDS AS ANTAGONISTS OF ADENOSINE A1 RECEPTORS
abstract Compound of Formula (I): wherein-R 1 represents an aryl or heteroaryl group optionally substituted with one or more substituents selected from the group consisting of halogen atoms. optionally substituted linear or branched alkyl radicals containing 1 to 8 carbon atoms, cycloalkyl, hydroxy, straight or branched, optionally substituted linear or branched oxy-containing radicals each containing alkyl moieties of 1 to 8 carbon atoms, cyano, or -CO2R ', at wherein R 1 represents a hydrogen atom either straight or branched, optionally substituted by a lower alkyl group; - R 2 represents a group selected from: a) optionally substituted linear or branched alkyl radicals containing 1 to 8 carbon atoms of a group substituted by one or more carboxyl groups (-COOH) and optionally substituted by one or more halogenab atoms) cycloalkyl groups substituted by one or more carboxylic groups (-COOH) and optionally substituted with one or more halogen atoms) straight or branched alkylcycloalkyl or cycloalkylalkyl groups substituted with one or more carboxyl groups (-COOH) and optionally substituted with one or more halogen atoms. The patent contains 12 more patent claims.
priorityDate 2007-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 37.